Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,831 | 322 | 87.4% |
| Education | $857.64 | 11 | 11.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $633.35 | 33 | $0 (2024) |
| Astellas Pharma US Inc | $518.53 | 15 | $0 (2024) |
| Incyte Corporation | $490.35 | 19 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $396.78 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $373.49 | 16 | $0 (2024) |
| Daiichi Sankyo Inc. | $340.75 | 13 | $0 (2024) |
| Lilly USA, LLC | $314.58 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $287.92 | 15 | $0 (2024) |
| Gilead Sciences, Inc. | $286.77 | 13 | $0 (2024) |
| PFIZER INC. | $278.17 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,599 | 103 | Astellas Pharma US Inc ($250.60) |
| 2023 | $2,814 | 119 | Incyte Corporation ($257.47) |
| 2022 | $1,973 | 95 | E.R. Squibb & Sons, L.L.C. ($234.52) |
| 2021 | $427.16 | 17 | AstraZeneca Pharmaceuticals LP ($135.77) |
All Payment Transactions
334 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: Oncology | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Oncology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Genetically Defined Disease | ||||||
| 11/19/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Oncology | ||||||
| 11/18/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.76 | General |
| Category: Oncology | ||||||
| 11/11/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.58 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: Oncology | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.76 | General |
| 10/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.54 | General |
| 10/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ARRAY BIOPHARMA INC | BRAFTOVI (Drug), MEKTOVI, TUKYSA | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $22.30 | General |
| 09/20/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $25.51 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 09/20/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $4.13 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 09/19/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Oncology | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Oncology | ||||||
| 09/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Rare Disease | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $32.81 | General |
| Category: ONCOLOGY | ||||||
About Stacy Jean
Stacy Jean is a Family healthcare provider based in Port Charlotte, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/31/2019. The National Provider Identifier (NPI) number assigned to this provider is 1154965341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stacy Jean has received a total of $7,814 in payments from pharmaceutical and medical device companies, with $2,599 received in 2024. These payments were reported across 334 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($6,831).
Practice Information
- Specialty Family
- Location Port Charlotte, FL
- Active Since 10/31/2019
- Last Updated 01/21/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154965341
Products in Payments
- OPDIVO (Biological) $457.07
- Enhertu (Drug) $267.83
- KEYTRUDA (Biological) $255.67
- MONJUVI (Drug) $224.94
- VERZENIO (Drug) $221.46
- Nubeqa (Drug) $191.77
- FOTIVDA (Drug) $179.28
- JAKAFI (Drug) $173.89
- Trodelvy (Drug) $162.63
- ENHERTU (Biological) $141.44
- BELEODAQ (Drug) $137.94
- IMBRUVICA (Drug) $133.04
- REBLOZYL (Biological) $123.24
- OPDUALAG (Drug) $121.34
- GILOTRIF (Drug) $120.77
- SCEMBLIX (Drug) $107.38
- Lenvima (Drug) $107.07
- ORGOVYX (Drug) $101.79
- Pomalyst (Drug) $99.06
- DOPTELET (Drug) $98.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Port Charlotte
Annmarie Richardson, Arnp, ARNP
Family — Payments: $10,380
Monica Gomez, Aprn, APRN
Family — Payments: $4,929
Stacey Stinger, Arnp, ARNP
Family — Payments: $4,185
Rose Marie Mccafferty, Arnp, ARNP
Family — Payments: $4,117
Jennifer Caluori, Arnp, ARNP
Family — Payments: $3,907
Natalie Desantis, Aprn, APRN
Family — Payments: $3,298